Skip to main content

Table 1 Alu115 of plasma DNA in subgroups of gastric cancer patients

From: Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA

Variable patients Alu115 p
No. %
Sex
 male 46 63.01 783.75 (521.35–1223.63) 0.045
 female 27 36.99 1484.50 (414.70–2295.50)  
AJCC primary tumor
 Tis-T1 12 16.44 818.4 (478.45–1732.75) 0.724
 T2 12 16.44 966.9 (432–1496.25)  
 T3 5 6.85 1153.5 (394.00–1238.75)  
 T4 44 60.27 1146.5 (676.7–1878.5)  
AJCC regional lymph nodes
 N0 31 42.47 1079.5 (408.2–1544) 0.362
 N1 8 10.96 1281 (1106–4104.25)  
 N2 14 19.18 1390.5 (606.65–1949.5)  
 N3 20 27.40 925.4 (579.55–2087)  
AJCC distant metastasis
 M0 63 86.30 1079.5 (552.95–1670) 0.275
 M1 10 13.70 1666.5 (754.25–2479.5)  
AJCC stage
0-I 19 26.03 1027.65 (408.2–1935) 0.676
II 11 15.07 1484.5 (400.7–1670)  
III 33 45.20 1065.5 (676.7–1572.5)  
IV 10 13.70 1666.5 (754.25–2479.5)  
Histopathologic grade
 middle -high 19 26.04 906.150 (359.50–1213.00) 0.811
 low 41 56.16 786.250 (411.45–1586.25)  
 unknow 13 17.81   
Lymphovascular invasion
 positive 18 24.66 1190.00 (551.04–1971.88) 0.653
 negative 12 16.44 1146.50 (400.70–1389.50)  
 unknow 43 58.90   
\